Good evening, here are the coronavirus updates you need to know tonight.

Top headlines:

  1. The European Union’s new vaccine passport excludes the Covishield vaccine (a common AstraZeneca brand) – which would block many Africans and Canadians from entry
  2. Canada’s COVID-19 death toll could be more than twice as high as previously reported, according to a new analysis
  3. Researchers are working to determine whether extra doses would be beneficial for those who are immunocompromised

In the past seven days, 4,401 cases were reported, down 24 per cent from the previous seven days. There were 120 deaths announced, down 31 per cent over the same period. At least 793 people are being treated in hospitals and 1,381,943 others are considered recovered.

Story continues below advertisement

Canada’s inoculation rate is 10th among countries with a population of one million or more people.

Images are unavailable offline.

Sources: Canada data is compiled from government websites, Johns Hopkins and COVID-19 Canada Open Data Working Group; international data is from Johns Hopkins University.


Coronavirus explainers: Coronavirus in maps and chartsTracking vaccine dosesLockdown rules and reopeningVaccine distribution planFour vaccines approved in CanadaEssential resources


Photo of the day

Images are unavailable offline.

Workers wearing personal protective equipment bury a coffin at a burial area for coronavirus disease victims in Cimahi, near Bandung, West Java province, Indonesia, on June 30, 2021.

ANTARA FOTO/Reuters


Coronavirus in Canada


Canada’s death toll from COVID-19 could be more than twice as high as previously reported, according to a new analysis of excess mortality rates.

Story continues below advertisement

COVID-19 vaccine: Third shots could become necessary for immunocompromised people, including the elderly and people with HIV, certain cancers and autoimmune disorders.

For now, the National Advisory Committee on Immunization is waiting for more evidence before it considers recommending third doses for any immunocompromised populations, said Mark Johnson, a spokesman for the Public Health Agency of Canada.

AstraZeneca: Health Canada is updating the label for the Oxford-AstraZeneca and Covishield COVID-19 vaccines to add capillary leak syndrome as a potential side effect.


Coronavirus around the world


Globe opinion


More reporting


Information centre

Sources: Canada data are compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data are from Johns Hopkins.

Story continues below advertisement

What are we missing? Email us: audience@globeandmail.com. Do you know someone who needs this newsletter? Send them to our Newsletters page.